FDA Investigator Don H Bark, PhD
Don H Bark, PhD has conducted inspections on 27 sites in 11 countries as of 11 May 2017. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
27
Last Inspection Date:
11 May 2017
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Netherlands,
Canada,
Italy,
Denmark,
United States of America,
Germany,
Spain,
Ireland,
Switzerland,
Finland,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Don H Bark, PhD:
Ademola O Daramola,
Alan P Kurtzberg,
Alexander M Kay,
Alice S Tsao,
Anastasia M Shields,
Angela E Glenn,
Anita Narula, PhD,
Anjali Shukla, PhD,
Anthony F Lorenzo,
Arlene M Badillo,
Ashar P Parikh,
Astrida B Mattson,
Barbara Janine Breithaupt,
Bijoy Panicker,
Bo Chi, PhD,
Bradley Dworak, PhD,
Brian D Nicholson,
Bruce H Mccullough,
Bryan L Mcguckin,
Carla J Lundi,
Caryn M Mcnab,
Charisse K Green,
Charles I Ann,
Charles M Edwards,
Charles R Cote, RIC,
Christian D Lynch (CDL),
Christina A Miller,
Christine A Harman, PhD,
Christopher D Leach,
Christopher R Czajka,
Christopher T Middendorf,
Connie P Rezendes,
Cynthia A Palmer,
Cynthia J Lee, MS,
Cynthia Jim, CSO,
Cynthia M Goudeau,
Dandan Wang, PhD,
David J Hafner,
David M Beltran,
David Perkins,
Dawn E Barkans,
Demitria J Xiradakis,
Dennis Cantellops Paite,
Dolores E Price,
Donald C Obenhuber, PhD,
Donald H Barks,
Douglas A Campbell,
Douglas C Kovacs,
Dr. Barbara D Paul, PhD,
Dr. Carmelo Rosa,
Edmund F Mrak, Jr,
Edward D Mcdonald,
Edwin Melendez,
Eileen A Liu,
Eliezar Ramos,
Farhana Khan,
Felix Maldonado,
Francis A Guidry,
Gayle S Lawson,
George J Flynn,
Geraldine D Sanders,
Gerard Pde Leon,
Gloria J Baca, MS,
Gwyn G Dickinson,
Heika R Bounds,
Heika R Tait,
Helen B Ricalde,
Jacqueline Mdiaz Albertini,
James I Giefer,
James L Dunnie, Jr,
James P Mcevoy,
James S Stuart, BS,
Jeffrey A Sommers,
Jeffrey D Meng,
Jen Sui,
Jennifer L Bridgewater,
Jennifer L Schmidt,
Jennifer M Gogley,
Jessica Chery,
Jessica L Pressley,
Joan M Cantellops Figueroa,
Joey V Quitania,
John A Podsadowski,
John P Mistler,
Jose Acruz Gonzalez,
Joshua P Wireman,
Kalavati Suvarna, PhD,
Kari M Johansen,
Kathleen R Jones, PhD,
Kathryn A Krentz,
Kathryn E Ogger,
Kenneth O Gee, PhD,
Kent C Faul,
Kevin D Kallander,
Kham Phommachanh,
Kim Lthomas Cruse,
Kip J Hanks,
Kristin M Abaonza,
Kristopher J Stanya, PhD,
Kula N Jha,
Larry K Austin,
Lata C Mathew, PhD,
Laura Fontan, MS,
Laurel A Beer,
Lawrence Y Lee, PhD,
LCDR Chad N Thompson,
LCDR Debra Emerson,
Linan Ha, PhD,
Linda M Cheny,
Lisa K Capron,
Lisa M Bellows,
Luis A Dasta,
Lydia I Rosas Marty,
Lynda L Perry, PhD,
M Edith Snyder,
Maida Henesian (NMI),
Marcellinus D Dordunoo,
Marcus A Ray,
Margaret M Annes,
Maria Pkelly Doggett, MBA,
Marie A Fadden,
Marijo B Kambere, PhD,
Mariza M Jafary,
Marjorie A Shapiro, PhD,
Mark W Babbitt,
Marlene G Swider,
Matthew B Casale,
Maxine H Wong,
Megan A Haggerty,
Mei Chiung Huang (Jo),
Meisha R Sampson,
Meisha Waters,
Meyer J Slobotsky,
Michael E Maselli,
Michael P Sheehan,
Michael R Klapal,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele L Obert,
Michelle Yclark Stuart,
Miguel A Martinez Perez,
Mihaly S Ligmond,
Mikel T Wright,
Mra Davism,
Mra Mcculloughj,
Mra Munizn,
Nadeem I Chaudhry,
Nancy A Saxenian Emmons,
Nancy G Schmidt,
Nebil A Oumer,
Nicole A Lloyd,
Omotunde O Osunsanmi,
Pal S Mayasandra,
Parul M Patel,
Patrick C Klotzbuecher,
Patsy J Domingo,
Paul A Bonneau,
Paul L Bellamy,
Paula A Trost,
Peter C Chow,
Philip F Istafanos, DMV, MS,
Prabhu P Raju,
Rachel C Harrington,
Randy L Self,
Rebecca Rodriguez,
Regina T Brown,
Richard E Needham,
Richard L Rutherford,
Robert C Coleman,
Robert C Steyert,
Robert D Tollefsen,
Rose Ashley,
Roy R Rinc,
Russell J Glapion,
S Lori Brown, PhD MPH,
Saleem A Akhtar,
Sangeeta M Khurana, PhD,
Sangeeta M Rataul,
Santos E Camara,
Sarah A Hassas,
Scott T Ballard,
Seneca D Toms,
Sharon K Thoma, PharmD,
Shawn R Gould,
Shuen G Chai,
Sidney B Priesmeyer,
Sixto M Mercado Rios,
Stephen D Eich,
Steven A Gonzales,
Steven C Madzo,
Steven M Weinman,
Sunitha K Rajaram, PhD,
Susan D Yuscius,
Susan F Laska, MS,
Susan M Jackson,
Susanna E Ford,
Terri L Dodds,
Thomas A Peter,
Thomas J Arista,
Tina S Roecklein,
Tonia F Bernard,
Tracey L Harris,
Tracy K Li,
Travis S Bradley,
Unnee Ranjan,
Uttaniti Limchumroon (Tom),
Veronica Fuentes, MS,
Virgilio F Pacio, CSO,
Vlada Matusovsky,
Wayne E Seifert,
Xiaokuang Lai, PhD,
Xiomara Copeland,
Yasamin Ameri,
Yumi J Hiramine,
Zachary A Bogorad,
Zhong Li, PhD,
Zhongren Wu
Don H Bark, PhD's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more